abiraterone has been researched along with cx 5461 in 1 studies
| Studies (abiraterone) | Trials (abiraterone) | Recent Studies (post-2010) (abiraterone) | Studies (cx 5461) | Trials (cx 5461) | Recent Studies (post-2010) (cx 5461) |
|---|---|---|---|---|---|
| 942 | 97 | 854 | 84 | 1 | 83 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azad, A; Banks, P; Bolton, D; Castro, E; Clark, AK; Clouston, D; Dehm, SM; Frydenberg, M; Furic, L; Goad, J; Goode, DL; Grummet, J; Hannan, RD; Hanson, AR; Harewood, L; Hedwards, S; Henzler, C; Huglo, A; Keerthikumar, S; Kourambas, J; Lawrence, MG; Lawrentschuk, N; Li, Y; Lister, N; Lopez-Campos, F; Mitchell, C; Moon, D; Murphy, DG; Niranjan, B; Norden, S; Obinata, D; Papargiris, M; Pearson, RB; Pedersen, J; Pezaro, CJ; Pook, D; Porter, LH; Rebello, RJ; Risbridger, GP; Ryan, A; Sandhu, S; Selth, LA; Sengupta, S; Snow, R; Taylor, RA; Thorne, H; Tilley, WD; Toivanen, R; Van Gramberg, J; Wang, H; Wong, SQ; Yang, R | 1 |
1 other study(ies) available for abiraterone and cx 5461
| Article | Year |
|---|---|
Patient-derived Models of Abiraterone- and Enzalutamide-resistant Prostate Cancer Reveal Sensitivity to Ribosome-directed Therapy.
Topics: Androstenes; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Azepines; Benzamides; Benzothiazoles; Drug Resistance, Neoplasm; Humans; Indoles; Male; Mice, Inbred NOD; Mice, SCID; Molecular Targeted Therapy; Naphthyridines; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; Proto-Oncogene Proteins c-pim-1; Ribosomes; RNA Polymerase I; Time Factors; Tumor Burden; Xenograft Model Antitumor Assays | 2018 |